Literature DB >> 22500930

Methyl effects on protein-ligand binding.

Cheryl S Leung1, Siegfried S F Leung, Julian Tirado-Rives, William L Jorgensen.   

Abstract

The effects of addition of a methyl group to a lead compound on biological activity are examined. A literature analysis of >2000 cases reveals that an activity boost of a factor of 10 or more is found with an 8% frequency, and a 100-fold boost is a 1 in 200 event. Four cases in the latter category are analyzed in depth to elucidate any unusual aspects of the protein-ligand binding, distribution of water molecules, and changes in conformational energetics. The analyses include Monte Carlo/free-energy perturbation (MC/FEP) calculations for methyl replacements in inhibitor series for p38α MAP kinase, ACK1, PTP1B, and thrombin. Methyl substitutions ortho to an aryl ring can be particularly effective at improving activity by inducing a propitious conformational change. The greatest improvements in activity arise from coupling the conformational gain with the burial of the methyl group in a hydrophobic region of the protein.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22500930      PMCID: PMC3353327          DOI: 10.1021/jm3003697

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  35 in total

1.  Protein-Ligand Complexes:  Computation of the Relative Free Energy of Different Scaffolds and Binding Modes.

Authors:  Julien Michel; Marcel L Verdonk; Jonathan W Essex
Journal:  J Chem Theory Comput       Date:  2007-09       Impact factor: 6.006

Review 2.  Molecular modeling of organic and biomolecular systems using BOSS and MCPRO.

Authors:  William L Jorgensen; Julian Tirado-Rives
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

3.  Contribution of conformer focusing to the uncertainty in predicting free energies for protein-ligand binding.

Authors:  Julian Tirado-Rives; William L Jorgensen
Journal:  J Med Chem       Date:  2006-10-05       Impact factor: 7.446

4.  Sulfonamide-related conformational effects and their importance in structure-based design.

Authors:  Stefan Senger; Chuen Chan; Máire A Convery; Julia A Hubbard; Gita P Shah; Nigel S Watson; Robert J Young
Journal:  Bioorg Med Chem Lett       Date:  2007-02-16       Impact factor: 2.823

5.  Role of the active-site solvent in the thermodynamics of factor Xa ligand binding.

Authors:  Robert Abel; Tom Young; Ramy Farid; Bruce J Berne; Richard A Friesner
Journal:  J Am Chem Soc       Date:  2008-02-12       Impact factor: 15.419

Review 6.  Computational approaches to molecular recognition.

Authors:  M L Lamb; W L Jorgensen
Journal:  Curr Opin Chem Biol       Date:  1997-12       Impact factor: 8.822

7.  Quinazolines with intra-molecular hydrogen bonding scaffold (iMHBS) as PI3K/mTOR dual inhibitors.

Authors:  Kevin K C Liu; Xiaojun Huang; Shubha Bagrodia; Jeffrey H Chen; Samantha Greasley; Hengmiao Cheng; Shaoxian Sun; Dan Knighton; Caroline Rodgers; Kristina Rafidi; Aihua Zou; Jiezhan Xiao; Shengyong Yan
Journal:  Bioorg Med Chem Lett       Date:  2010-12-10       Impact factor: 2.823

8.  Identification and optimization of N3,N6-diaryl-1H-pyrazolo[3,4-d]pyrimidine-3,6-diamines as a novel class of ACK1 inhibitors.

Authors:  David J Kopecky; Xiaolin Hao; Yi Chen; Jiasheng Fu; XianYun Jiao; Juan C Jaen; Mario G Cardozo; Jinsong Liu; Zhulun Wang; Nigel P C Walker; Holger Wesche; Shyun Li; Ellyn Farrelly; Shou-Hua Xiao; Frank Kayser
Journal:  Bioorg Med Chem Lett       Date:  2008-11-01       Impact factor: 2.823

9.  Vancomycin analogs: Seeking improved binding of d-Ala-d-Ala and d-Ala-d-Lac peptides by side-chain and backbone modifications.

Authors:  Siegfried S F Leung; Julian Tirado-Rives; William L Jorgensen
Journal:  Bioorg Med Chem       Date:  2009-07-10       Impact factor: 3.641

10.  Biphenyl amide p38 kinase inhibitors 3: Improvement of cellular and in vivo activity.

Authors:  Richard Angell; Nicola M Aston; Paul Bamborough; Jacky B Buckton; Stuart Cockerill; Suzanne J deBoeck; Chris D Edwards; Duncan S Holmes; Katherine L Jones; Dramane I Laine; Shila Patel; Penny A Smee; Kathryn J Smith; Don O Somers; Ann L Walker
Journal:  Bioorg Med Chem Lett       Date:  2008-06-18       Impact factor: 2.823

View more
  55 in total

1.  Ligand-accelerated ortho-C-H alkylation of arylcarboxylic acids using alkyl boron reagents.

Authors:  Peter S Thuy-Boun; Giorgio Villa; Devin Dang; Paul Richardson; Shun Su; Jin-Quan Yu
Journal:  J Am Chem Soc       Date:  2013-11-08       Impact factor: 15.419

Review 2.  Structural models of ligand-gated ion channels: sites of action for anesthetics and ethanol.

Authors:  Richard W Olsen; Guo-Dong Li; Martin Wallner; James R Trudell; Edward J Bertaccini; Erik Lindahl; Keith W Miller; Ronald L Alkana; Daryl L Davies
Journal:  Alcohol Clin Exp Res       Date:  2013-10-24       Impact factor: 3.455

3.  Leveraging Atropisomerism to Obtain a Selective Inhibitor of RET Kinase with Secondary Activities toward EGFR Mutants.

Authors:  Sean T Toenjes; Valeria Garcia; Sean M Maddox; Gregory A Dawson; Maria A Ortiz; F Javier Piedrafita; Jeffrey L Gustafson
Journal:  ACS Chem Biol       Date:  2019-08-29       Impact factor: 5.100

Review 4.  Applying thermodynamic profiling in lead finding and optimization.

Authors:  Gerhard Klebe
Journal:  Nat Rev Drug Discov       Date:  2015-01-23       Impact factor: 84.694

5.  Synthesis and structure-activity relationships of novel phenoxyacetamide inhibitors of the Pseudomonas aeruginosa type III secretion system (T3SS).

Authors:  John D Williams; Matthew C Torhan; Venugopal R Neelagiri; Carson Brown; Nicholas O Bowlin; Ming Di; Courtney T McCarthy; Daniel Aiello; Norton P Peet; Terry L Bowlin; Donald T Moir
Journal:  Bioorg Med Chem       Date:  2015-01-13       Impact factor: 3.641

6.  Structure-Activity Relationship Studies for Enhancer of Zeste Homologue 2 (EZH2) and Enhancer of Zeste Homologue 1 (EZH1) Inhibitors.

Authors:  Xiaobao Yang; Fengling Li; Kyle D Konze; Jamel Meslamani; Anqi Ma; Peter J Brown; Ming-Ming Zhou; Cheryl H Arrowsmith; H Ümit Kaniskan; Masoud Vedadi; Jian Jin
Journal:  J Med Chem       Date:  2016-08-11       Impact factor: 7.446

7.  Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention.

Authors:  Anil Desphande; Gang Xia; LeeAnn J Boerma; Kimberly K Vines; Venkatram R Atigadda; Susan Lobo-Ruppert; Clinton J Grubbs; Fariba L Moeinpour; Craig D Smith; Konstantin Christov; Wayne J Brouillette; Donald D Muccio
Journal:  Bioorg Med Chem       Date:  2013-12-01       Impact factor: 3.641

8.  [Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile.

Authors:  Longxiang Bai; Ziyuan Li; Jiajia Chen; Nga N Chung; Brian C Wilkes; Tingyou Li; Peter W Schiller
Journal:  Bioorg Med Chem       Date:  2014-02-19       Impact factor: 3.641

9.  Nickel/Photoredox-Catalyzed Methylation of (Hetero)aryl Chlorides Using Trimethyl Orthoformate as a Methyl Radical Source.

Authors:  Stavros K Kariofillis; Benjamin J Shields; Makeda A Tekle-Smith; Michael J Zacuto; Abigail G Doyle
Journal:  J Am Chem Soc       Date:  2020-04-10       Impact factor: 15.419

10.  Virtual screening and optimization yield low-nanomolar inhibitors of the tautomerase activity of Plasmodium falciparum macrophage migration inhibitory factor.

Authors:  Markus K Dahlgren; Alvaro Baeza Garcia; Alissa A Hare; Julian Tirado-Rives; Lin Leng; Richard Bucala; William L Jorgensen
Journal:  J Med Chem       Date:  2012-10-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.